Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity

Metabolism: Clinical and Experimental

Volumn 45, Issue 3, 1996, Pages 370-377

  Oscarsson, Jan ^a   Ottosson, Malin ^a   Johansson, Jan Ove ^a   Wiklund, Olov ^a   Mårin, Per ^a   Björntorp, Per ^a   Bengtsson, Bengt Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LIPOPROTEIN; LIPOPROTEIN A; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RECOMBINANT GROWTH HORMONE; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CASE REPORT; CHROMOPHOBE ADENOMA; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; GROWTH HORMONE DEFICIENCY; HUMAN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029881479     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90293-0     Document Type: Article

References (64)

1. Edén S, Jansson J-O, Oscarsson J: Sexual dimorphism of growth hormone secretion, in Isaksson O, Binder C, Hall K, et al (eds): Growth Hormone - Basic and Clinical Aspects. Amsterdam, The Netherlands, Elsevier Science, 1987, pp 129-151
2. Oscarsson J, Olofsson S-O, Bondjers G, et al: Differential fects of continuous versus intermittent administration of growth hormone to hypophysectomized female rats on serum lipoproteins and their apoproteins. Endocrinology 125:1638-1649, 1989
3. Oscarsson J, Olofsson S-O, Vikman K, et al: Growth hormone regulation of serum lipoproteins in the rat: Different growth hormone regulatory principles for apolipoprotein (apo) B and the sexually dimorphic apo E concentrations. Metabolism 40:1191-1198, 1991
4. Oscarsson J, Carlsson LMS, Bick T, et al: Evidence for the role of the secretory pattern of growth hormone in the regulation of serum concentrations of cholesterol and apolipoprotein E. J Endocrinol 128:433-438, 1991
5. Sjöberg A, Oscarsson J, Edén S, et al: Continuous but not intermittent administration of growth hormone to hypophysectomized rats increases apolipoprotein-E secretion from cultured hepatocytes. Endocrinology 134:790-798, 1994
6. Stolar MW, Baumann G: Secretory patterns of growth hormone during basal periods in man. Metabolism 35:883-888, 1986
7. Winer LM, Shaw MA, Baumann G: Basal plasma growth hormone levels in man: New evidence for rhythmicity of growth hormone secretion. J Clin Endocrinol Metab 70:1678-1686, 1990
8. Eriksson L, Frankenne F, Edén S, et al: Growth hormone 24-h serum profiles during pregnancy - Lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol 96:949-953, 1989
9. Hartman ML, Veldhuis JD, Johnson ML, et al: Augmented growth hormone (GH) secretory burst frequency and amplitude mediate enhanced GH secretion during a two-day fast in normal men. J Clin Endocrinol Metab 74:757-765, 1992
10. Asplin CM, Faria ACS, Carlsen EC, et al: Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 69:239-245, 1989
11. Jørgensen JOL, Møller N, Lauritzen T, et al: Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: Effects on circulating insulin-like growth factor-I and metabolic indices. J Clin Endocrinol Metab 70:1616-1623, 1990
12. Pal BR, Phillips PE, Matthews DR, et al: Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:542-549, 1992
13. Laursen T, Jørgensen JOL, Christiansen JS: Metabolic response to growth hormone (GH) administered in a pulsatile, continuous or combined pattern. Endocrinol Metab 1:33-40, 1994
14. Friedman M, Byers SO, Elek SR: Pituitary growth hormone essential for regulation of serum cholesterol. Nature 225:464-467, 1970
15. Friedman M, Byers SO, Rosenman RH, et al: Effect of subacute administration of human growth hormone on various serum lipid and hormone levels of hypercholesterolemic and normocholesterolemic subjects. Metabolism 23:905-912, 1974
16. Salomon F, Cuneo RC, Hesp R, et al: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 321:1797-1803, 1989
17. Edén S, Wiklund O, Oscarsson J, et al: Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb 13:296-301, 1993
18. Rudling M, Norstedt G, Olivercrona H, et al: Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Proc Natl Acad Sci USA 89:6983-6987, 1992
19. Oscarsson J, Ottosson M, Wiklund O, et al: Low dose continuously infused growth hormone results in increased lipoproin(a) and decreased low density lipoprotein cholesterol concentrations in middle-aged men. Clin Endocrinol (Oxf) 41:109-116, 1994
20. Blakett PR, Weech PK, McConathy WJ, et al: Growth hormone in the regulation of hyperlipidemia. Metabolism 31:117-120, 1982
21. Schaefer GB, Greger NG, Fesmire JD, et al: Lipids and apolipoproteins in growth hormone-deficient children during treatment. Metabolism 43:1457-1461, 1994
22. Elam MB, Wilcox HG, Solomon SS, et al: In vivo growth hormone treatment stimulates secretion of very low density lipoprotein by the isolated perfused rat liver. Endocrinology 131:2717-2722, 1992
23. Sjöberg A, Oscarsson J, Boström K, et al: Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology 130:3356-3364, 1992
24. Rudling M, Angelin B: Loss of resistance to dietary cholesterol in the rat after hypophysectomy: Importance of the presence of growth hormone for hepatic low density lipoprotein-receptor expression. Proc Natl Acad Sci USA 90:8851-8855, 1993
25. Murase T, Yamada N, Matsuzaki F: The in vitro effect of growth hormone on adipose tissue lipoprotein lipase in rats. Life Sci 28:199-201, 1981
26. Vikman-Adolfsson K, Oscarsson J, Nilsson-Ehle P, et al: Growth hormone but not gonadal steroids influence lipoprotein lipase and hepatic lipase activity in hypophysectomized rats. J Endocrinol 140:203-209, 1994
27. Hoogerbrugge VD, Linden N, Jansen H, et al: Growth hormone and thyroxine affect lipoprotein metabolism in hypothyroid and hypophysectomized rats. J Endocrinol 125:403-407, 1990
28. Asayama K, Amemiya S, Kusano S, et al: Growth-hormone-induced changes in postheparin plasma lipoprotein lipase and hepatic triglyceride lipase activities. Metabolism 33:129-131, 1984
29. Murase T, Yamada N, Ohsawa N, et al: Decline of postheparin plasma lipoprotein lipase in acromegalic patients. Metabolism 29:666-672, 1980
30. Richelsen B, Pedersen SB, Børglum JD, et al: Growth hormone treatment of obese women for 5 wk: Effect on body composition and adipose tissue LPL activity. Am J Physiol 266:E211-E216, 1994
31. Nilsson-Ehle P, Carlström S, Belfrage P: Rapid effects on lipoprotein lipase activity in adipose tissue of humans after carbohydrate and lipid intake. Scand J Clin Lab Invest 35:373-378, 1975
32. Sadur CN, Yost TJ, Eckel RH: Fat feeding decreases insulin responsiveness of adipose tissue lipoprotein lipase. Metabolism 33:1043-1047, 1984
33. Johansson J-O, Oscarsson J, Bjarnason R, et al: Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults. I. Effects on insulin-like growth factor-I (IGF-I), GH, and IGF binding proteins and glucose homeostasis. Metabolism 45:362-369, 1996
34. Johansson S, Bondjers G, Fager G, et al: Serum lipids and apolipoprotein levels in women with acute myocardial infarction. Arteriosclerosis 8:742-749, 1988
35. Wiklund O, Angelin B, Olofsson S-O, et al: Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia. Lancet 335:1360-1363, 1990
36. Wiklund O, Fager G, Craig IH, et al: Alphalipoprotein cholesterol in relation to acute myocardial infarction and its risk factors. Scand J Clin Lab Invest 40:239-247, 1980
37. Keil U, Kuulasmaa K: WHO MONICA Project: Risk factors. Int J Epidemiol 18:S46-S55, 1989 (suppl 1)
38. Peterson J, Olivecrona T, Bengtsson-Olivecrona G: Distribuon of lipoprotein lipase and hepatic lipase between plasma and tissues: Effect of hypertriglyceridemia. Biochim Biophys Acta 837:262-270, 1985
39. Bengtsson-Olivecrona G, Olivecrona T: Assay of lipoprotein lipase and hepatic lipase, in Converse CA, Skinner ER (eds): Lipoprotein Analysis - A Practical Approach. Oxford, UK, Oxford University Press, 1992, pp 169-185
40. Spooner PM, Garrison MM, Scow RO: Regulation of mammary and adipose tissue lipoprotein lipase and blood triacylglycerol in rats during late pregnancy. J Clin Invest 60:702-708, 1977
41. Dole VP, Meinertz H: Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 235:2595-2599, 1960
42. Karpe F, Olivecrona T, Walldius G, et al: Lipoprotein lipase in plasma after an oral fat load: Relation to free fatty acids. J Lipid Res 33:975-984, 1992
43. Smith U, Sjöström L, Björntorp P: Comparisons of two methods for determining human adipose cell size. J Lipid Res 13:822-824, 1972
44. Rosén T, Edén S, Larson G, et al: Cardiovascular risk factors in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 129:195-200, 1993
45. Cuneo RC, Salomon F, Watts GF, et al: Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism 42:1519-1523, 1993
46. de Boer H, Blok GJ, Voerman HJ, et al: Serum lipid levels in growth hormone-deficient men. Metabolism 43:199-203, 1994
47. Winter RJ, Green OC: Effect of thyroxine and growth hormone on the hypercholesterolemia of growth hormone deficiency. Metabolism 33:54-57, 1984
48. Cryer A: Tissue lipoprotein lipase activity and its action in lipoprotein metabolism. Int J Biochem 13:525-541, 1981
49. Farese RV Jr, Yost TJ, Eckel RH: Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans. Metabolism 40:214-216, 1991
50. Bengtsson B-Å, Edén S, Lönn L, et al: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317, 1993
51. Baynes C, Henderson AD, Richmond W, et al: The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes. Eur J Clin Invest 22:341-346, 1992
52. 2 cholesterol. Metabolism 36:949-952, 1987
53. Gibbons GF: Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J 268:1-13, 1990
54. Kraft HG, Menzel HJ, Hoppichler F, et al: Changes of genetic apolipoprotein phenotypes caused by liver transplantation: Implications for apolipoprotein synthesis. J Clin Invest 83:137-142, 1989
55. Dahlén G, Slunga L, Lindblom B: Importance of Lp(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes. Clin Genet 46:46-51, 1994
56. Henriksson P, Angelin B, Berglund L: Hormonal regulation of serum Lp(a) levels: Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest 89:1161-1171, 1992
57. Ho KY, Evans WS, Blizzard RM, et al: Effects of sex and age on 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 64:51-58, 1987
58. Kelly JJ, Rajkovic IA, O'Sullivan AJ, et al: Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf ) 39:561-567, 1993
59. Levitsky LL, Scanu AM, Gould SH: Lipoprotein(a) levels in black and white children and adolescents with IDDM. Diabetes Care 14:283-287, 1991
60. Haffner SM, Tuttle KR, Rainwater DL: Decrease of lipoprotein(a) with improved glycemic control in IDDM subjects. Diabetes Care 14:302-307, 1991
61. Rader DJ, Brewer HB: Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein. JAMA 267:1109-1112, 1992
62. Adlercreutz H, Kerstell J, Svanborg A: Simultaneous estimation of plasma cholesterol, total and individual phospholipids, triglycerides, free fatty acids and cortisol, and urinary estrogens, total 17-ketosteroids, individual 11-deoxy-17-ketosteroids, total 17-ketogenic steroids and pregnanediol during the menstrual cycle and in early pregnancy. Ann Med Exp Fenn 45:285-292, 1967
63. Zechner R, Desoye G, Schweditsch MO, et al: Fluctuations of plasma lipoprotein(a) concentrations during pregnancy and post partum. Metabolism 35:333-336, 1986
64. Panteghini M, Pagani F: Serum concentrations of lipoprotein(a) during normal pregnancy and postpartum. Clin Chem 37:2009-2010, 1991